Similar articles for PMID: 22227384

Year	Number of Results
1996	1
1997	1
2003	1
2004	1
2005	6
2006	9
2007	11
2008	9
2009	9
2010	11
2011	16
2012	12
2013	12
2014	11
2015	11
2016	7
2017	5
2018	4
2019	5
2020	7
2021	1
2022	5
2023	1
2024	0

1

Breakthrough invasive mould infections in patients treated with caspofungin.

Pang KA, Godet C, Fekkar A, Scholler J, Nivoix Y, Letscher-Bru V, Massias L, Kauffmann-Lacroix C, Elsendoorn A, Uzunov M, Datry A, Herbrecht R. Pang KA, et al. J Infect. 2012 Apr;64(4):424-9. doi: 10.1016/j.jinf.2011.12.015. Epub 2011 Dec 29. J Infect. 2012. PMID: 22227384

2

Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.

Madureira A, Bergeron A, Lacroix C, Robin M, Rocha V, de Latour RP, Ferry C, Devergie A, Lapalu J, Gluckmana E, Socié G, Ghannoum M, Ribaud P. Madureira A, et al. Int J Antimicrob Agents. 2007 Dec;30(6):551-4. doi: 10.1016/j.ijantimicag.2007.07.026. Int J Antimicrob Agents. 2007. PMID: 18029149

3

High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.

Lafaurie M, Lapalu J, Raffoux E, Breton B, Lacroix C, Socié G, Porcher R, Ribaud P, Touratier S, Molina JM. Lafaurie M, et al. Clin Microbiol Infect. 2010 Aug;16(8):1191-6. doi: 10.1111/j.1469-0691.2009.03050.x. Epub 2009 Sep 3. Clin Microbiol Infect. 2010. PMID: 19735276 Free article.

4

Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.

Chou LS, Lewis RE, Ippoliti C, Champlin RE, Kontoyiannis DP. Chou LS, et al. Pharmacotherapy. 2007 Dec;27(12):1644-50. doi: 10.1592/phco.27.12.1644. Pharmacotherapy. 2007. PMID: 18041885

5

Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.

Pavie J, Lacroix C, Hermoso DG, Robin M, Ferry C, Bergeron A, Feuilhade M, Dromer F, Gluckman E, Molina JM, Ribaud P. Pavie J, et al. J Clin Microbiol. 2005 Sep;43(9):4902-4. doi: 10.1128/JCM.43.9.4902-4904.2005. J Clin Microbiol. 2005. PMID: 16145172 Free PMC article. Review.

6

The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).

Lortholary O, Fernández-Ruiz M, Perfect JR. Lortholary O, et al. J Antimicrob Chemother. 2016 Nov;71(suppl 2):ii31-ii36. doi: 10.1093/jac/dkw394. J Antimicrob Chemother. 2016. PMID: 27880667

7

Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study).

Jarque I, Tormo M, Bello JL, Rovira M, Batlle M, Julià A, Tabares S, Rivas C, Fernández-Sevilla A, García-Boyero R, Debén G, González-Campos J, Capote FJ, Sanz MA; Spanish Pethema Group. Jarque I, et al. Med Mycol. 2013 Feb;51(2):150-4. doi: 10.3109/13693786.2012.693213. Epub 2012 Jun 19. Med Mycol. 2013. PMID: 22712457 Clinical Trial.

8

The misleading effect of serum galactomannan testing in high-risk haematology patients receiving prophylaxis with micafungin.

Vena A, Bouza E, Álvarez-Uría A, Gayoso J, Martín-Rabadán P, Cajuste F, Guinea J, Gómez Castellá J, Alonso R, Munoz P. Vena A, et al. Clin Microbiol Infect. 2017 Dec;23(12):1000.e1-1000.e4. doi: 10.1016/j.cmi.2017.05.006. Epub 2017 May 12. Clin Microbiol Infect. 2017. PMID: 28506782 Free article.

9

Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.

Yamaguchi M, Kurokawa T, Ishiyama K, Aoki G, Ueda M, Matano S, Takami A, Yamazaki H, Sawazaki A, Yamauchi H, Yoshida T, Nakao S. Yamaguchi M, et al. Ann Hematol. 2011 Oct;90(10):1209-17. doi: 10.1007/s00277-011-1277-1. Epub 2011 Jun 22. Ann Hematol. 2011. PMID: 21695388 Clinical Trial.

10

Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.

Fortún J, Muriel A, Martín-Dávila P, Montejo M, Len O, Torre-Cisneros J, Carratalá J, Muñoz P, Fariñas C, Moreno A, Fresco G, Goikoetxea J, Gavaldá J, Pozo JC, Bodro M, Vena A, Casafont F, Cervera C, Silva JT, Aguado JM; Grupo de Estudio de Infección en Pacientes Trasplantados-Grupo de Estudio de Micología Médica (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica), and Red Española de Investigación en Patología Infecciosa. Fortún J, et al. Liver Transpl. 2016 Apr;22(4):427-35. doi: 10.1002/lt.24391. Liver Transpl. 2016. PMID: 26709146 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

129 results

Results by year